Molecule engineered to target neovascularization in AMD

A genetically engineered molecule designed to kill cancers by destroying their rapidly growing blood vessels offers a new line of attack against age-related macular degeneration (AMD) and other retinal conditions, said Alan Garen, PhD.

Related Content

---

Tamsulosin-intraoperative floppy iris syndrome link is urged to be considered by primary care physicians

Article

---

Anticipate silodosin-IFIS link, surgeon says

Article

---

ASCRS, AAO have new advice for primary care physicians about alpha blockers and IFIS

Article

---

Techniques can help surgeons manage IFIS

Article

---

Medications for ED can harm optic nerve

Article

---

Alternative strategies successful in managing IFIS

Article